Bristol-Myers Squibb Beats Earnings Estimates and More - Presented by: The Aol. On Network

Bristol-Myers Squibb reported higher than expected quarterly earnings on Tuesday, helped by cost cuts and lower taxes. There were concerns over a possible delay in completing its marketing application for a high-profile cancer drug. BMY posted Q1 earnings of 56 cents per share, beating estimates of 43 cents a share, while revenue dipped to $3.81 billion, missing estimates of $3.89 billion. Bristol-Myers Squibb also announced the acquisition of iPierian for $175 million.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 118.44 2.86 ▼ 2.36%
BAC $ 17.77 0.11 ▼ 0.62%
FTR $ 5.15 0.43 ▲ 9.11%
S $ 3.34 0.03 ▼ 0.89%
TWTR $ 29.27 1.74 ▼ 5.61%
PBR $ 6.35 0.45 ▼ 6.62%
MU $ 19 0.49 ▲ 2.65%
GE $ 25.87 0.23 ▼ 0.88%

As of 8/3/2015, 04:15 PM